Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study
International Journal of Colorectal Disease · 2025
DOI: 10.1007/s00384-024-04798-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2025. Verfasst von Yoshiro Omori und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan. Hauptthemen laut MEDLINE: Trifluridine, Neutropenia, Colorectal Neoplasms, Pyrrolidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan.
- Department of Surgery, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan. s1980matsu@gmail.com.
- Department of Surgery, Japan Community Healthcare Organization Tokuyama Central Hospital, 1-1 Koda-Cho, Shunan, Yamaguchi, 745-0822, Japan.
Zitieren
APA
Omori, Y., Matsukuma, S., Kawa, M., Ishimitsu, K., Kawaoka, T., Akiyama, N., Tokuno, K., Fujita, Y., Sato, S., & Yamamoto, S. (2025). Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04798-2
Vancouver
Omori Y, Matsukuma S, Kawa M, Ishimitsu K, Kawaoka T, Akiyama N, et al. Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study. International Journal of Colorectal Disease. 2025. doi:10.1007/s00384-024-04798-2
BibTeX
@article{Omori2025,
author = {Omori, Yoshiro and Matsukuma, Satoshi and Kawa, Mikiko and Ishimitsu, Kazuki and Kawaoka, Toru and Akiyama, Norio and Tokuno, Kazuhisa and Fujita, Yuji and Sato, Shinya and Yamamoto, Shigeru},
title = {Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study},
journal = {International Journal of Colorectal Disease},
year = {2025},
doi = {10.1007/s00384-024-04798-2}
}
EUVIMED